POMGNT1 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: As shown for other genes implicated in dystroglycanopathies [11,12], it has already been suggested [10] that the severity of the disease correlates with the strength of the disruptive effect of POMGNT1 mutations.